The first staking ETF for INJ has finally gotten the green light from Nasdaq—but it can’t be bought yet.
Fact: Nasdaq approved the listing of the Canary Staked INJ ETF (ticker: INJC), the first staking ETF for Injective in the U.S. (CoinDesk, Nov. 5, citing an SEC Form 8-A filing dated Nov. 3). The fund holds spot INJ and aims to stake at least 90% of its holdings, with an annual fee of 1.10%. Important: this is only listing approval—the ETF can start trading only after its S-1 registration becomes effective with the SEC. INJ itself is up around 8% over the past 24 hours, to about $8.28 (live data at around 20:00 WIB), after briefly touching $8.59 this afternoon; from its low of $6.82 on Nov. 3, it’s up around 22%.
My take: This is an institutional milestone for INJ—the first route into U.S. brokerage accounts with staking rewards. But let’s temper the euphoria: without an effective S-1, there are no real fund flows yet, and around 30% of gross staking rewards go toward fees shared by the sponsor, staking provider, and custodian. Today’s rally is more about expectations than money already flowing in.
What I’m watching: when INJC’s S-1 becomes effective and whether real inflows arrive after trading begins—plus whether BTC stays below $80,000 tonight, since INJ also pulled back this afternoon along with the market.
What do you think: will staking ETFs like this become a template for other altcoins, or will they only work for big names?
This is my analysis, not financial advice—always DYOR.
#Injective #ETF $INJ
Fact: Nasdaq approved the listing of the Canary Staked INJ ETF (ticker: INJC), the first staking ETF for Injective in the U.S. (CoinDesk, Nov. 5, citing an SEC Form 8-A filing dated Nov. 3). The fund holds spot INJ and aims to stake at least 90% of its holdings, with an annual fee of 1.10%. Important: this is only listing approval—the ETF can start trading only after its S-1 registration becomes effective with the SEC. INJ itself is up around 8% over the past 24 hours, to about $8.28 (live data at around 20:00 WIB), after briefly touching $8.59 this afternoon; from its low of $6.82 on Nov. 3, it’s up around 22%.
My take: This is an institutional milestone for INJ—the first route into U.S. brokerage accounts with staking rewards. But let’s temper the euphoria: without an effective S-1, there are no real fund flows yet, and around 30% of gross staking rewards go toward fees shared by the sponsor, staking provider, and custodian. Today’s rally is more about expectations than money already flowing in.
What I’m watching: when INJC’s S-1 becomes effective and whether real inflows arrive after trading begins—plus whether BTC stays below $80,000 tonight, since INJ also pulled back this afternoon along with the market.
What do you think: will staking ETFs like this become a template for other altcoins, or will they only work for big names?
This is my analysis, not financial advice—always DYOR.
#Injective #ETF $INJ